EQRX RSI Chart
Last 7 days
20.5%
Last 30 days
11.3%
Last 90 days
10.8%
Trailing 12 Months
-51.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 40.4M | 52.4M | 60.7M | 0 |
2022 | 6.6M | 12.8M | 19.0M | 25.1M |
2021 | 181.8K | 266.5K | 351.3K | 436.0K |
2020 | 0 | 0 | 0 | 97.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 09, 2023 | ah equity partners bio ii, l.l.c. | sold | - | - | -5,000,000 | - |
Nov 09, 2023 | borisy alexis | back to issuer | - | - | -18,810,000 | executive chairman |
Nov 09, 2023 | abernethy amy | back to issuer | - | - | -200,000 | - |
Nov 09, 2023 | horning sandra | back to issuer | - | - | -470,250 | - |
Nov 09, 2023 | conde jorge | back to issuer | - | - | -11,433,700 | - |
Nov 09, 2023 | conde jorge | back to issuer | - | - | -5,000,000 | - |
Nov 09, 2023 | conde jorge | back to issuer | - | - | -17,438,500 | - |
Nov 09, 2023 | conde jorge | back to issuer | - | - | -19,192,000 | - |
Nov 09, 2023 | nallicheri melanie | back to issuer | - | - | -3,851,150 | chief executive officer |
Nov 09, 2023 | nallicheri melanie | acquired | 1,385,670 | 2.21 | 626,999 | chief executive officer |
Which funds bought or sold EQRX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 22, 2024 | MetLife Investment Management, LLC | sold off | -100 | -380,843 | - | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | sold off | -100 | -2,966,450 | - | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | sold off | -100 | -353,526 | - | -% |
Feb 26, 2024 | PERCEPTIVE ADVISORS LLC | sold off | -100 | -10,000 | - | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | sold off | -100 | -241,000 | - | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | sold off | -100 | -25,000 | - | -% |
Feb 16, 2024 | BLUEFIN CAPITAL MANAGEMENT, LLC | sold off | -100 | -2,646,760 | - | -% |
Feb 15, 2024 | GTS SECURITIES LLC | sold off | -100 | -48,869 | - | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -274,052 | - | -% |
Feb 15, 2024 | Westchester Capital Management, LLC | sold off | -100 | -16,923,100 | - | -% |
Unveiling EQRx, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to EQRx, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 47.0B | 6.8B | -7.88 | 6.87 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 19.1B | 2.0B | -57.66 | 9.56 | ||||
BMRN | 15.5B | 2.5B | 75.52 | 6.28 | ||||
INCY | 12.0B | 3.8B | 16.12 | 3.19 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.83 | 48.09 | ||||
APLS | 5.2B | 524.1M | -12.37 | 9.85 | ||||
AXSM | 3.5B | 251.0M | -11.81 | 13.94 | ||||
ARWR | 3.1B | 240.7M | -6.52 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.5K | 3.09 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 411.3M | 28.39 | 4.49 | ||||
NVAX | 627.6M | 996.6M | -1.57 | 0.63 | ||||
CRBP | 467.4M | 881.7K | -13.85 | 481.06 | ||||
INO | 261.3M | 4.9M | -1.93 | 53.69 | ||||
IBIO | 6.6M | 2.1M | -0.24 | 2.14 |
EQRx, Inc. News
Income Statement (Quarterly) | |||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Revenue | 2.6% | 16,485,000 | 16,068,000 | 15,442,000 | 12,668,000 | 8,209,000 | 4,091,000 | 182,000 | 127,667 | 73,333 | 19,000 | 144,000 | - |
Operating Expenses | 10.6% | 101,548,000 | 91,836,000 | 101,798,000 | 100,730,000 | 90,366,000 | 79,090,000 | 85,691,000 | 94,801,000 | 39,976,000 | 34,639,000 | 26,959,000 | 177,645,000 |
S&GA Expenses | 9.0% | 23,404,000 | 21,476,000 | 27,277,000 | 29,232,000 | 34,095,000 | 31,792,000 | 32,263,000 | 38,585,000 | 16,176,000 | 13,223,000 | 10,282,000 | 8,562,000 |
R&D Expenses | -54.7% | 19,729,000 | 43,574,000 | 70,933,000 | 71,498,000 | 56,271,000 | 47,298,000 | 53,428,000 | 56,216,000 | 23,800,000 | 21,416,000 | 16,677,000 | 169,083,000 |
EBITDA Margin | - | - | - | - | - | - | -226 | -226 | -226 | - | - | - | - |
EBT Margin | - | - | - | - | - | - | -229 | -229 | -229 | - | - | - | - |
Net Income | -13.3% | -82,631,000 | -72,956,000 | -82,551,000 | -22,177,000 | -85,092,000 | -82,546,000 | 20,726,000 | 1,224,000 | -39,890,000 | -34,526,000 | -26,817,000 | -177,613,000 |
Net Income Margin | 14.5% | -4.29 | -5.02 | -6.74 | -6.72 | -7.68 | -7.85 | -7.93 | -229 | -711 | -938 | -1,375 | -2,577 |
Free Cashflow | 19.6% | -61,907,000 | -77,041,000 | -85,990,000 | -106,753,000 | -62,118,000 | -65,579,000 | -53,951,000 | -80,488,000 | -42,015,000 | -37,561,000 | -23,564,000 | -173,261,000 |
Balance Sheet | |||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2021Q1 | 2020Q4 | 2019Q4 |
Assets | -5.4% | 1,240 | 1,311 | 1,384 | 1,455 | 1,543 | 1,608 | 1,674 | 1,729 | 554 | 553 | 536 | 518 | 501 | 20.00 |
Current Assets | -3.8% | 1,235 | 1,284 | 1,355 | 1,428 | 1,524 | 1,588 | 1,655 | 1,706 | 2.00 | 1.00 | 0.00 | - | 492 | 19.00 |
Cash Equivalents | 27.5% | 316 | 248 | 368 | 494 | 998 | 864 | 1,623 | 1,679 | 456 | 500 | 537 | - | 490 | 19.00 |
Net PPE | -100.0% | - | 2.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | - | - | 3.00 | 0.00 |
Liabilities | 10.0% | 69.00 | 63.00 | 70.00 | 66.00 | 143 | 134 | 126 | 215 | 74.00 | 81.00 | - | 50.00 | 18.00 | 28.00 |
Current Liabilities | 15.8% | 66.00 | 57.00 | 60.00 | 52.00 | 63.00 | 55.00 | 57.00 | 40.00 | 2.00 | 0.00 | 0.00 | 0.00 | 14.00 | 28.00 |
Shareholder's Equity | -6.2% | 1,171 | 1,248 | 1,314 | 1,389 | 1,400 | 1,475 | 1,549 | 1,515 | 456 | 494 | 527 | 0.00 | 482 | - |
Retained Earnings | -12.1% | -765 | -683 | -610 | -527 | -505 | -420 | -337 | -358 | -72.17 | -31.84 | 48.00 | -751* | -258 | -8.51 |
Additional Paid-In Capital | 0.3% | 1,936 | 1,931 | 1,924 | 1,917 | 1,907 | 1,897 | 1,886 | 1,873 | 5.00 | 37.00 | 0.00 | 0.00 | 741 | - |
Shares Outstanding | 0.4% | 485 | 483 | 481 | 479 | 476 | 472 | 471 | 469 | 321 | 315 | 311 | - | 298 | - |
Cashflow (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Cashflow From Operations | 19.5% | -61,907 | -76,891 | -85,546 | -105,796 | -62,104 | -65,430 | -53,938 | -80,384 | -41,966 | -37,309 | -23,521 | -172,243 | -53,113 | -13,547 | -2,603 |
Share Based Compensation | -28.3% | 4,869 | 6,790 | 7,592 | 9,225 | 9,432 | 9,988 | 12,906 | 22,410 | 2,016 | 1,016 | 784 | - | - | - | - |
Cashflow From Investing | 394.9% | 129,874 | -44,041 | -40,359 | -398,417 | 194,916 | -693,763 | -13.00 | -4,104 | -49.00 | -252 | -43.00 | -1,018 | -1,173 | -711 | -78.00 |
Cashflow From Financing | 182.4% | 209 | 74.00 | 127 | 327 | 774 | 361 | -1,323 | 1,306,560 | -1,673 | 345 | 71,256 | 496,919 | 108,154 | 88,403 | 22,003 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Operating expenses: | ||||
Research and development | $ 19,729 | $ 56,271 | $ 134,236 | $ 156,997 |
General and administrative | 23,404 | 34,095 | 72,157 | 98,150 |
Restructuring | 58,415 | 88,789 | ||
Total operating expenses | 101,548 | 90,366 | 295,182 | 255,147 |
Loss from operations | (101,548) | (90,366) | (295,182) | (255,147) |
Other income (expense): | ||||
Change in fair value of contingent earn-out liability | (110) | (2,706) | 4,556 | 90,863 |
Change in fair value of warrant liabilities | 2,530 | (197) | 4,501 | 4,934 |
Interest income, net | 16,485 | 8,209 | 47,995 | 12,482 |
Other expense, net | 12 | (32) | (8) | (44) |
Total other income (expense), net | 18,917 | 5,274 | 57,044 | 108,235 |
Net loss | (82,631) | (85,092) | (238,138) | (146,912) |
Other comprehensive income (loss), net of tax: | ||||
Foreign currency translation adjustments | (14) | 33 | (3) | 49 |
Unrealized holding gains (losses) on short-term investments | 132 | 370 | 403 | (1,672) |
Comprehensive loss, net of tax | (82,513) | (84,689) | (237,738) | (148,535) |
Net loss attributable to common stockholders - basic | (82,631) | (85,092) | (238,138) | (146,912) |
Net loss attributable to common stockholders - diluted | $ (82,631) | $ (85,092) | $ (238,138) | $ (146,912) |
Net income (loss) per share - basic (in dollars per share) | $ (0.17) | $ (0.18) | $ (0.49) | $ (0.31) |
Net income (loss) per share - diluted (in dollars per share) | $ (0.17) | $ (0.18) | $ (0.49) | $ (0.31) |
Weighted average common shares outstanding - basic (in shares) | 484,229,709 | 475,565,990 | 482,135,388 | 473,101,935 |
Weighted average common shares outstanding - diluted (in shares) | 484,229,709 | 475,565,990 | 482,135,388 | 473,101,935 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 315,676 | $ 494,136 |
Short-term investments | 896,624 | 905,150 |
Prepaid expenses and other current assets | 22,206 | 28,800 |
Restricted cash | 633 | |
Total current assets | 1,235,139 | 1,428,086 |
Property and equipment, net | 2,627 | |
Restricted cash | 633 | |
Right-of-use asset | 3,804 | |
Other investments | 4,000 | 4,000 |
Other non-current assets | 1,151 | 15,866 |
Total assets | 1,240,290 | 1,455,016 |
Current liabilities: | ||
Accounts payable | 8,103 | 19,950 |
Accrued expenses | 55,623 | 29,596 |
Lease liability, current | 2,060 | 2,370 |
Total current liabilities | 65,786 | 51,916 |
Non-current liabilities: | ||
Contingent earn-out liability | 2,604 | 7,160 |
Warrant liabilities | 792 | 5,293 |
Lease liability, non-current | 1,461 | |
Restricted stock repurchase liability | 188 | 324 |
Total liabilities | 69,370 | 66,154 |
Commitments and contingencies (note 13) | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value, 2,000,000 shares authorized; no shares issued and outstanding as of September 30, 2023 and December 31, 2022 | ||
Common stock, $0.0001 par value; 1,250,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 537,540,870 and 538,549,210 shares issued as of September 30, 2023 and December 31, 2022, respectively; and 484,965,823 and 478,674,305 shares outstanding at September 30, 2023 and December 31, 2022, respectively | 49 | 49 |
Additional paid-in capital | 1,936,346 | 1,916,550 |
Accumulated other comprehensive income (loss) | 252 | (148) |
Accumulated deficit | (765,727) | (527,589) |
Total stockholders' equity | 1,170,920 | 1,388,862 |
Total liabilities and stockholders' equity | $ 1,240,290 | $ 1,455,016 |